These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 25271822
1. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia. Gevonden M, Booij J, van den Brink W, Heijtel D, van Os J, Selten JP. JAMA Psychiatry; 2014 Dec 01; 71(12):1364-72. PubMed ID: 25271822 [Abstract] [Full Text] [Related]
2. Psychotic reactions to daily life stress and dopamine function in people with severe hearing impairment. Gevonden MJ, Myin-Germeys I, van den Brink W, van Os J, Selten JP, Booij J. Psychol Med; 2015 Jun 01; 45(8):1665-74. PubMed ID: 25482840 [Abstract] [Full Text] [Related]
6. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M. Am J Psychiatry; 1998 Jun 01; 155(6):761-7. PubMed ID: 9619147 [Abstract] [Full Text] [Related]
7. Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis. Bloemen OJ, de Koning MB, Gleich T, Meijer J, de Haan L, Linszen DH, Booij J, van Amelsvoort TA. Eur Neuropsychopharmacol; 2013 Feb 01; 23(2):126-32. PubMed ID: 22591910 [Abstract] [Full Text] [Related]
8. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H, van Balkom A, Lammertsma AA, van Berckel BN. Eur Neuropsychopharmacol; 2013 Nov 01; 23(11):1423-31. PubMed ID: 23876376 [Abstract] [Full Text] [Related]
10. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia. Frankle WG, Paris J, Himes M, Mason NS, Mathis CA, Narendran R. Biol Psychiatry; 2018 Apr 15; 83(8):707-714. PubMed ID: 29325847 [Abstract] [Full Text] [Related]
11. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M. Biol Psychiatry; 2009 Jun 15; 65(12):1091-3. PubMed ID: 19167701 [Abstract] [Full Text] [Related]
17. Striatal dopamine release in schizophrenia comorbid with substance dependence. Thompson JL, Urban N, Slifstein M, Xu X, Kegeles LS, Girgis RR, Beckerman Y, Harkavy-Friedman JM, Gil R, Abi-Dargham A. Mol Psychiatry; 2013 Aug 15; 18(8):909-15. PubMed ID: 22869037 [Abstract] [Full Text] [Related]
18. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence. Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED. Int J Neuropsychopharmacol; 2015 Jan 20; 18(7):pyu119. PubMed ID: 25603861 [Abstract] [Full Text] [Related]
19. Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride. Ota M, Ogawa S, Kato K, Masuda C, Kunugi H. Neurosci Res; 2015 Dec 20; 101():1-5. PubMed ID: 26232153 [Abstract] [Full Text] [Related]
20. Striatal dopamine D2/D3 receptor availability in male smokers. Yang YK, Yao WJ, McEvoy JP, Chu CL, Lee IH, Chen PS, Yeh TL, Chiu NT. Psychiatry Res; 2006 Jan 30; 146(1):87-90. PubMed ID: 16343861 [Abstract] [Full Text] [Related] Page: [Next] [New Search]